Antibody against the GABA-A receptor is a biomarker of autoimmune encephalopathy that occurs across the lifespan, and disproportionately affects children. In this test-specific episode of the "Answers...From the Lab" podcast, Andrew McKeon,...
Sleep Disorder Testing - Mayo Clinic Laboratories
Determining orexin-A/ hypocretin-1 levels through CSF testing provides a sensitive and specific result to guide appropriate treatment for patients....
Cayuga Medical Center and Mayo Clinic Laboratories - Insights
A world-class investment Collaboration resulting in world-class, value-based patient care Achieving greatness for yourself and your patients...
January 2020 — Laboratory Genetics and Genomics - Insights
A 19 year old female with a complex phenotype suggestive of a mitochondrial disorder had mitochondrial DNA sequencing performed three times at an outside...
Sleep Disorder Testing - Mayo Clinic Laboratories
Determining orexin-A/ hypocretin-1 levels through CSF testing provides a sensitive and specific result to guide appropriate treatment for patients....
Hematology journal lauds HIT testing research - Insights
A study involving Mayo Clinic investigators that examined new approaches to the diagnosis of heparin-induced thrombocytopenia has been met with enthusiasm in the scientific community....
July 2019 — Cardiovascular - Insights
A 50-year-old man who was known to have systemic hypertension developed sudden onset of severe back pain with associated diaphoresis. He lost...
Mayo Clinic Laboratory and pathology research roundup: September 28 - Insights
features: Effect of probiotics on incident ventilator-associated pneumonia in critically Ill patients: A randomized clinical trial....
Mayo Clinic Sustains Reduced Blood Culture Contamination in the Laboratory - Insights
A recent article in MedicalLab Management, authored by Mayo Clinic staff, discusses how to sustain reduced blood-culture contamination in clinical laboratories....
Mayo Clinic Laboratory and pathology research roundup: March 22 - Insights
This Feature Includes: A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis....